Pamidronate in the treatment of childhood SAPHO syndrome

Rheumatology

Volumn 43, Issue 10, 2004, Pages 1246-1251

  Kerrison, C ^a   Davidson, J E ^a   Cleary, A G ^a   Beresford, M W ^a  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Childhood; CRMO; Pamidronate; SAPHO

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; CORTICOSTEROID; DICLOFENAC; IBUPROFEN; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; ANALGESIA; ARTICLE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG RESPONSE; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; FEMALE; FEVER; FLU LIKE SYNDROME; FUNCTIONAL ASSESSMENT; HUMAN; LONG TERM CARE; PAIN; PEDIATRIC HOSPITAL; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SAPHO SYNDROME; SCHOOL CHILD; SELF EVALUATION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; WELLBEING;

ACQUIRED HYPEROSTOSIS SYNDROME; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; DIPHOSPHONATES; FEMALE; HUMANS; PAIN; TREATMENT OUTCOME;

EID: 5444268031     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh295     Document Type: Article

References (48)

1. Boutin RD, Resnick D. The SAPHO Syndrome: an evolving concept for unifying several idiopathic disorders of bone and skin. Am J Roentgenol 1998;170:585-91.
2. Kahn MF, Khan MA. The SAPHO syndrome. Baillieres Clin Rheumatol 1994;8:333-62.
3. Kahn MF. Why the 'SAPHO' syndrome. J Rheumatol 1995; 22:2017-19.
4. Giedion A, Holthusen W, Masel LF, Vischer D. Subacute and chronic 'symmetrical' osteomyelitis. Ann Radiol 1972;15:329-42.
5. Earwaker JWS, Cotten A. SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol 2003;32:311-27.
6. Sugimoto H, Tamura K, Fujii T. The SAPHO syndrome: defining the radiological spectrum of diseases comprising the syndrome. Eur Radiol 1998;8:800-6.
7. Suei Y, Taguchi A, Tanimoto K. Diagnostic points and possible origin of osteomyelitis in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome: a radiographic study of 77 mandibular osteomyelitis cases. Rheumatology 2003;42:1398-403.
8. Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology 2004;43:658-61.
9. Kahn MF. Psoriatic arthritis and synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome. Curr Opin Rheumatol 1993;5:428-35.
10. Girschick HJ, Huppertz HI, Harmsen D, Krauspe R, Muller-Hermelink HK, Papadopoulos T. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol 1999;30:59-65.
11. Beretta-Piccoli BC, Sauvain MJ, Gal I et al. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature. Eur J Pediatr 2000;159:594-601.
12. Azouz EM, Jurik AG, Bernard C. Sternocostoclavicular hyperostosis in children: a report of eight cases. Am J Roentgenol 1998; 171:461-6.
13. Courtney PA, Hosking DJ, Fairburn KJ, Deighton CM. Treatment of SAPHO with pamidronate. Rheumatology 2002;41:1196-8.
14. Marshall H, Bromilow J, Thomas AL, Arden NK. Pamidronate: a novel treatment for the SAPHO syndrome'? Rheumatology 2002; 41:231-3.
15. Guignard S, Bob-Deslandre C, Sayag-Boukris V, Kahan A. Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 2002;69:392-6.
16. Allgrove J. Biphosphonates. Arch Dis Child 1997;76:73-5.
17. Åström E, Söderhäll S. Beneficial effect of long term intravenous bisphosphonate treatment in osteogenesis imperfecta. Arch Dis Child 2002;86:356-64.
18. Batch JA, Couper JJ, Rodda C, Cowell CT, Zacharin M. Use of bisphosphonate therapy for osteoporosis in childhood and adolescence. J Paediatr Child Health 2003;39:88-92.
19. Banerjee I, Shortland GJ, Evans WD. Osteogenesis imperfecta and intravenous pamidronate. Arch Dis Child 2002;87:562-3.
20. Pennanen N, Lapinjoki S, Urtti A, Monkkonen J. Effect of liposomal and free bisphosphonates on the IL-1, IL-6 and TNF-α secretion from RAW 264 cells in vitro. Pharm Res 1995;12:916-22.
21. Maksymowych WP. Bisphosphonates for arthritis - a confusing rationale. J Rheumatol 2003;30:430-4.
22. Huk OL, Zukor DJ, Antoniou J, Petit A. Effect of pamidronate on the stimulation of macrophage TNF-α release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis. J Orthop Res 1003;21:81-7.
23. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclical administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998;339:947-52.
24. Devogelaer JP. Uses of bisphosphonates: osteogenesis imperfecta. Curr Opin Pharmacol 2002;2:748-53.
25. Bembi B, Parma A, Bottega M et al. Intravenous pamidronate treatment in osteogenesis imperfecta. J Pediatr 1997;131:622-5.
26. Noguera A, Ros JB, Pavia C et al. Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children. J Pediatr Endocrinol Metab 2003;16:529-36.
27. Brumsen C, Hamdy NA, Papapoulos SE. Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine (Baltimore) 1997;76: 266-83.
28. Steelman J, Zeitler P. Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions. J Pediatr 2003;142:417-23.
29. Shaw NJ, Boivin CM, Crabtree NJ. Intravenous pamidronate in juvenile osteoporosis. Arch Dis Child 2000;83:143-5.
30. Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 2003;88: 4569-75.
31. Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997;12:1746-52.
32. Watts RA, Crisp AJ, Hazleman BL, Daunt SO, Jenner JR. Arthroosteitis - a clinical spectrum. Br J Rheumatol 1993;32:403-7.
33. Job-Deslandre C, Krebs S, Khan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Joint Bone Spine 2001;68:245-51.
34. Schuster T, Bielek J, Dietz HG, Belohradsky BH. Chronic recurrent multifocal osteomyelitis (CRMO). Eur J Pediatr Surg 1996;6:45-51.
35. van Doornum S, Barraclough D, McColl G, Wicks I. SAPHO: rare or just not recognised? Semin Arthritis Rheum 2000;30:70-7.
36. Marini JC. Do bisphosphonates make children's bones better or brittle? N Engl J Med 2003;349:423-6.
37. Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S. Bisphosphonate-induced osteopetrosis. N Engl J Med 2003;349: 457-63.
38. Zeitlin L, Rauch F, Plotkin H, Glorieux FH. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 2003;111:1030-6.
39. Crisp AJ. Pamidronate for SAPHO syndrome. Rheumatology 2003;42:491.
40. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 1999;104: 1363-74.
41. Lissoni P, Cazzaniga M, Barni S et al. Acute effects on pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2. Eur J Cancer 1997;33:304-6.
42. Sauty A, Pecherstorfer M, Zimmer-Roth I et al. Interleukin-6 and tumor necrosis factor α levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone 1996;18:133-9.
43. Maksymowych WP, Aaron SL, Russell AS. Treatment of refractory symphysitis pubis with intravenous pamidronate. J Rheumatol 2001;28:2754-7.
44. Speden D, Nicklason F, Francis H, Ward J. The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA). Aust NZ J Med 1997;27:307-10.
45. Garske LA Bell SC. Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Chest 2002;121:1363-4.
46. Maksymowych WP, Lambert R, Jhangri GS et al. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol 2001;28: 144-55.
47. Dougados M. Disease controlling antirheumatic therapy in spondyloarthropathy. J Rheumatol 2001;28(Suppl):16-20.
48. Winchester R. Psoriatic arthritis and the spectrum of syndromes related to SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome. Curr Opin Rheumatol 1999;11:251-6.